Liensinine raw Powder CAS 2586-96-1 Liensinine

CAS:2586-96-1

MF:C37H42N2O6

MW:610.74

EINECS:683-151-0

Specification​: 99% min Liensinine

Sample:Liensinine Powder

Packaging:1kg/bag, 25kg/drum

Brand: Henrikang

Appearance:white

Storage: Cool Dry Place

Shelf Life: 2 Years

Test Method: HPLC

Liensinine Usage and Synthesis.

Liensinine has many cardiovascular activities such as lowering blood pressure, slowing down heart rate, inhibiting myocardial contractility and anti-arrhythmia. Liensinine can also reduce the lipid peroxidation damage and protect the myocardial injury caused by ischemia reperfusion in rats. Liensinine can reduce the production of lipid peroxide MDA and enhance the activities of SOD and GSH-Px in serum, thereby reducing a series of cell damage reactions caused by free radicals. It can also effectively increase the content of local ATP in the ischemic area, reduce the content of lactic acid, and significantly improve the energy metabolism of cerebral ischemic tissue, thus improving the neurological dysfunction of cerebral ischemia reperfusion rats and narrowing the scope of cerebral infarction.

Uses of Liensinine.

Liensinine can reduce the production of lipid peroxide MDA, enhance the activity of serum SOD and GSH-Px, and thus reduce the series of cell damage reactions caused by free radicals. It can also effectively increase the content of local ATP in the ischemic area, reduce the content of lactic acid, and significantly improve the energy metabolism of cerebral ischemic tissue, thus improving the neurological dysfunction of cerebral ischemia reperfusion rats and narrowing the scope of cerebral infarction.

Preparation of Liensinine.

Product Method of Liensinine.